Evidence map›Paper›PMID 36311242›Full record

ArticleFrontiers in physiology2022

Annexin A1 exerts renoprotective effects in experimental crescentic glomerulonephritis.

Robert Labes, Lei Dong, Ralf Mrowka, Sebastian Bachmann, Sibylle von Vietinghoff, Alexander Paliege

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robert LabesDepartment of Anatomy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Lei DongNephrology Department, Tongji Hospital, Tongji College, Huazhong University of Science and Technology, Wuhan, China.
Ralf MrowkaKlinik für Innere Medizin III, AG Experimentelle Nephrologie, Universitätsklinikum Jena, Jena, Germany.
Sebastian BachmannDepartment of Anatomy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sibylle von VietinghoffNephrology Section, First Medical Clinic, University Clinic and Rheinische Friedrich-Wilhelms Universität Bonn, Bonn, Germany.
Alexander PaliegeDivision of Nephrology, Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-resolving inflammation plays a critical role during the transition from renal injury towards end-stage renal disease. The glucocorticoid-inducible protein annexin A1 has been shown to function as key regulator in the resolution phase of inflammation, but its role in immune-mediated crescentic glomerulonephritis has not been studied so far.

Indexed as

annexin A1 (AnxA1)crescentic glomerulonephritisepoxydocosapentaenoic acids (EDPs)nephrotoxic serum nephritisneutrophil granulocyte (PMN)prostaglandin E2 (PGE2)renal fibrosisresolution of inflammation

Identifiers

PMID36311242
PMCPMC9605209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.